Evaxion Biotech Stock

November 04, 2021

Its proprietary AI platforms include PIONEER an immuno-oncology platform. Find the latest Evaxion Biotech AS EVAX stock quote history news and other vital information to help you with your stock trading and investing.

Evaxion Biotech Crunchbase Company Profile Funding

The average twelve-month price target for Evaxion Biotech AS is 2067 with a high price target of 2300 and a low price target of 1800.

Evaxion Biotech stock

. Evaxion Biotech AS a clinical-stage artificial intelligence AI-immunology platform company identifies and develops novel immunotherapies for the treatment of various cancers bacterial diseases and viral infections. Depositary Receipt Common Stock Securities Offered. Evaxion Biotech Sees Positive Data in Covid-19 Vaccine Program Jun. If you experience any issues with.

26 2021 GLOBE NEWSWIRE -- Evaxion Biotech AS Nasdaq. Press Release reported on. In other words for every 100000 Evaxion Biotech AS shares traded daily on the market roughly 190 shares are currently held short. View the latest EVAX stock quote and chart on MSN Money.

You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. Evaxion Biotechs stock is trading at a volume of 296 million shares as of 1230 EST. EVAX youre not aloneBut with the companys stock up nearly 200 in todays pre-market session it might be time to get acquainted with. View real-time EVAX stock price and news along with industry-best analysis.

If you havent heard of Evaxion Biotech NASDAQ. On average they expect Evaxion Biotech ASs stock price to reach 2067 in the next year. Evaxion Biotech AS is a Denmark-based clinical-stage biotechnology company which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. To gain some more context you can compare Evaxion Biotech ASs short interest ratio against those of similar companies.

EVAX Evaxion or the Company a clinical-stage biotechnology company specializing in the development of AI-drive. Evaxion Biotech - Investor Relations. Evaxion Biotech AS American Depositary Share EVAX Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. News Evaxion Biotech AS ADREVAX.

Their forecasts range from 1800 to 2300. Evaxion Biotech ASs SIR currently stands at 019. We have developed our AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system so we can. The companys stock price has collected 1436 of gains in the last five trading sessions.

On average Wall Street analysts predict that. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Evaxion Biotech AS NASDAQEVAX is not the most popular stock in this group but hedge fund interest is still above average. No news for in the past two years.

Gainers Evaxion Biotech AS NASDAQEVAX shares climbed 179 to 1817 after dropping over 10 on WednesdayNerdWallet Inc. Evaxion Biotech AS employs 35 staff and has a market cap total outstanding stock value of 1574 million. Complete Evaxion Biotech AS ADR stock information by Barrons. Evaxion Biotech Announces Filing of Registration Statement in the US for Proposed Follow-on Public Offering to Raise.

Get the latest Evaxion Biotech AS - ADR EVAX real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. We are an AI-immunology TM platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. 3 2021 at 829 am. NASDAQNRDS jumped 60 to 2886.

Evaxion Biotech AS has completed an IPO in the amount of 30 million. Evaxion Biotech As share price could stay at 1800 by Mar 2 2022. InvestorsObserver Nov 04 2021 0931 ET. According to the issued ratings of 3 analysts in the last year the consensus rating for Evaxion Biotech AS stock is Buy based on the current 3 buy ratings for EVAX.

Evaxion Biotech AS has completed an IPO in the amount of 30 million. Its last market close was 725 a decrease of 132 over the previous week. 3 analysts have issued 12 month price objectives for Evaxion Biotech ASs stock. American Depositary Shares Security Type.

The Price to Earnings PE ratio a key valuation measure is calculated by dividing the. EDEN a bacterial disease platform. Our overall hedge fund sentiment score for EVAX is 613. Evaxion Biotech AS stocks EVAXUS are listed on the NASDAQ and all prices are listed in US Dollars.

Evaxion Biotech AS NASDAQEVAX went up by 1332 from its latest closing price compared to the recent 1-year high of 1034. At Evaxion Biotech we promise to treat your data with respect and will not share your information with any third party. ET Evaxion Biotech started at buy with 23 stock price target at Ladenburg Thalmann. This suggests a possible upside of 1793 from the stocks current price.

The average Evaxion Biotech A stock price prediction forecasts a potential downside of NA from the current EVAX share price of 792. Dive deeper with interactive charts and top stories of Evaxion Biotech AS. Thinking about buying stock in Evaxion Biotech Stratasys Maxar Technologies Concert Pharmaceuticals or Gogo.

Evax News Today Evaxion Biotech A S Marketbeat

Evaxion Biotech Gives Back Gains Following Collaboration Supply Agreement With Merck Seeking Alpha